CI
GSK icon

Cavalier Investments’s GSK GSK Stock Holding History

Cavalier Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,264
Closed -$108K – 138
2018
Q4 		$108K Buy
+2,264
New +$111K 0.03% 150
2018
Q2 		– Sell
-2,021
Closed -$99K – 171
2018
Q1 		$99K Buy
+2,021
New +$94.1K 0.04% 148

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Cavalier Investments's GSK Position: Q1 2019 in Review

Cavalier Investments sold out of GSK (GSK) in Q1 2019, closing a stake of 2,264 shares — an estimated $108K sold.

Cavalier Investments first reported a position in GSK in Q1 2018 and held it in 2 quarters. The position peaked at $108K in Q4 2018. 847 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

  • Cavalier Investments reported no remaining GSK position as of Q1 2019 after selling out during the quarter.
  • Cavalier Investments sold 2,264 GSK shares in Q1 2019, an estimated $108K.
  • Cavalier Investments first reported a position in GSK in Q1 2018 and held it in 2 quarters.
  • Cavalier Investments's GSK position peaked at $108K in Q4 2018.
  • 847 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on Cavalier Investments's 13F filing for Q1 2019, filed 3 May 2019.